Clinical Outcomes
Over a median follow-up of 22 months (range, 6 to 65), all 6 patients remained free of sustained VT (Figure 3). Pt-2 was free from VT but died of severe pneumonia 2 years after the procedure. LVEF did not seem to be impacted by the procedure (Table 1).